Skip to main content

MD Anderson rolls out lung CT screening

Following Wednesday’s release of comprehensive data from the National Lung Screening Trial, which demonstrated a 20 percent reduction in lung cancer mortality resulting from CT screening, MD Anderson Cancer Center publicized its aims to begin implementing lung screening for heavy smokers—without reimbursement from payors.

Part of the University of Texas, MD Anderson Cancer Center in Houston becomes one of the first major providers to adopt CT screening for lung cancer, after having contributed 780 patients to the National Cancer Institute’s National Lung Screening Trial (NLST).

This week, investigators from half-a-dozen NLST participating sites published an updated and more extensive analysis of the NLST’s November findings in the New England Journal of Medicine. The trial revealed that low-dose lung CT dramatically lowered lung cancer mortality compared with standard x-rays, with the results dramatic enough to spur the National Cancer Institute to cut short its multi-institution study.

The authors of the analysis indicated that forthcoming cost-effectiveness studies would be critical to implementing the NLST findings on a broad scale. Notwithstanding, MD Anderson followed up by announcing its intention to screen patients over 50 who had a history of smoking a pack of cigarettes a day for at least 20 years.

As more in-depth cost-benefit studies continue, the cancer center said it would charge $400 per screening, a price it said was “worth it,” both for deriving clinical benefit and in view of the high costs associated with treating the disease in advanced stages, which often does not stave off death.

A major concern of the study was CT’s 96 percent false-positive rate, which would result in substantial costs and additional testing if implemented according to the NLST’s trial criteria. Still, Reginald Munden, MD, a professor of diagnostic radiology and lead investigator at MD Anderson, argued, “There are more costs associated with treating lung cancer.

“This is a major finding for lung cancer patients and health care policy in the U.S.,” Munden continued. The hospital emphasized that by providing complementary services for patients, including risk assessment and tobacco cessation counseling, it would further improve early detection of the disease.

To read a more in-depth story on the results of the National Lung Screening Trial, click here.

Last updated on July 1, 2011 at 9:24 am EST

View the original article here

Popular posts from this blog

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...

Who should get a CT scan to screen for lung cancer?

By Jenifer Goodwin HealthDay Reporter THURSDAY, June 30 (HealthDay News) -- Annual low-dose CT scans cut the death rate from lung cancer by 20% in heavy smokers and formerly heavy smokers, compared to those who get annual chest X-rays, according to the results of a major National Cancer Institute study released on Wednesday. Experts are calling the findings a major advance in efforts to combat lung cancer deaths. By catching the cancer early, the tumors can be removed surgically -- hopefully before they've spread and become very difficult to cure. "This is a momentous time in the history of public health research," said Dr. Otis Brawley, chief medical officer of the American Cancer Society. "The NLST [National Lung Screening Trial] is the best-designed and best-performed lung cancer screening study in history." Yet the findings raise as many questions as they answer, said Dr. Harold Sox, a professor emeritus of medicine at Dartmouth Medical School who wrote an...

Lung Cancer - A Look at the Numbers

It is a known fact that lung cancer is the second leading cause of death and the biggest cause of cancer deaths in both sexes in the West. It accounts for about 30% of all deaths from cancer. The unfortunate reality is that many of those deaths could have been prevented -- fully 85% of all lung cancers are caused by smoking. This includes those who breathe in second-hand smoke from others in the vicinity. If everyone were to give up smoking, the incidence of lung cancer would drop dramatically. After smoking, radon exposure is the second most common cause of lung cancer in America. The US Environmental Protection Agency estimates that about 21,000 deaths are caused every year by radon exposure. Among various ethnic groups, the incidence of lung cancer is highest among African Americans. This is because of a high cultural propensity among this group to take up the smoking habit. This is also one of the deadliest forms of cancer around. To give some comparative statistics, the five-year ...